• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 ONYX; AGENT, INJECTABLE, EMBOLIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 ONYX; AGENT, INJECTABLE, EMBOLIC Back to Search Results
Model Number UNK-NV-ONYX
Device Problem Entrapment of Device (1212)
Patient Problem Foreign Body In Patient (2687)
Event Date 05/16/2019
Event Type  Injury  
Manufacturer Narrative
It was reported that 4.77ml of onyx 18 was injected, afterwards the catheter was attempted to be retrieved but resistance was encountered.The marathon catheter broke into two parts (after 28 minutes).Break occurred at the end of the soft part about 25cm from the tip of marathon.About 25cm of the catheter tip was left in the patient's body.As the event was reportable to a regulatory authority, an investigation was required.The event was investigated to determine cause.As the device was still in use at the time this investigation was completed, no analysis could be performed.There was no indication that the event was related to a potential manufacturing issue and no dhr was requested, so a device history record review was not performed.The investigation determined that this was a known event, and therefore no new formal investigation was required.Common sequences of events and contributing factors that can lead to this known event are documented in the risk management file.Per the marathon ifu (instructions for use): precautions ¿ ¿if catheter entrapment is suspected (with any embolic agent), fast catheter retrieval technique may result in catheter shaft separation and potential vascular damage.Do not apply more than 20 cm of traction to catheter to minimize risk of catheter separation.¿ per the onyx les ifu: warnings ¿ ¿do not allow more than 1 cm of the onyx les to reflux back over catheter tip.Angioarchitecture, vasospasm, excessive onyx les reflux, or prolonged injection time may result in difficult catheter removal and potential entrapment.Excessive force to remove an entrapped catheter may cause serious intracranial hemorrhage.The long-term effects of an entrapped catheter that is left in a patient are unknown, but potentially could include clot formation, infection, or catheter migration.¿ no corrective action is required.These types of events will be monitored as part of post market vigilance complaint trending and monitoring.Reference mdr# 2029214-2019-00536.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received report that the onyx was injected from the feeder of the left m3 in an avm case.4.77ml of onyx 18 was injected, afterwards the catheter was attempted to be retrieved but resistance was encountered.The marathon catheter broke into two parts (after 28 minutes).Break occurred at the end of the soft part about 25cm from the tip of marathon.About 25cm of the catheter tip was left in the patient's body.The separated distal segment of the catheter is in the m3 to the ostium of the internal carotid artery (ica).The amount onyx reflux (1cm or more) was not notice and was more than desired in the peripheral blood vessel and the plug became long.Onyx embolus was used in an arteriovenous malformation (avm) case.The anatomy was severe in tortuous.The devices were each prepared per the instructions for use (ifu).The pause of onyx injection was one minute to a half at most.The patient was given antithrombotic therapy (ozagrel).The patient was reported to have been asymptomatic post the intervention.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ONYX
Type of Device
AGENT, INJECTABLE, EMBOLIC
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer Contact
katcha taylor
9775 toledo way
irvine, CA 92618
7635263305
MDR Report Key8685457
MDR Text Key147571304
Report Number2029214-2019-00537
Device Sequence Number1
Product Code MFE
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P030004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 06/10/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberUNK-NV-ONYX
Device Lot NumberASK-UNK
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/16/2019
Initial Date FDA Received06/10/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Disability;
Patient Age19 YR
-
-